Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.26 PLN | +0.32% | -7.40% | -11.83% |
29/02 | Pharmena S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Pharmena S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Sales 2022 | 19.02M 4.72M 394M | Sales 2023 | 299K 74.19K 6.19M | Capitalization | 79.08M 19.62M 1.64B |
---|---|---|---|---|---|
Net income 2022 | -1M -248K -20.69M | Net income 2023 | 28M 6.95M 579M | EV / Sales 2022 | 3.73 x |
Net Debt 2022 | 8.55M 2.12M 177M | Net cash position 2023 | 22.05M 5.47M 456M | EV / Sales 2023 | 191 x |
P/E ratio 2022 |
-39.7
x | P/E ratio 2023 |
2.73
x | Employees | 15 |
Yield 2022 * |
-
| Yield 2023 |
12% | Free-Float | 29.7% |
1 day | +0.32% | ||
1 week | -7.40% | ||
Current month | -24.94% | ||
1 month | -30.13% | ||
3 months | -7.40% | ||
6 months | -2.19% | ||
Current year | -11.83% |
Managers | Title | Age | Since |
---|---|---|---|
Konrad Palka
CEO | Chief Executive Officer | - | 12/02/12 |
Chief Tech/Sci/R&D Officer | - | 12/02/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Director/Board Member | 61 | - | |
Jacek Dauenhauer
BRD | Director/Board Member | 56 | - |
Date | Price | Change | Volume |
---|---|---|---|
02/24/02 | 6.26 | +0.32% | 2,459 |
30/24/30 | 6.24 | -3.41% | 15,724 |
29/24/29 | 6.46 | -0.62% | 13,992 |
26/24/26 | 6.5 | -4.13% | 12,070 |
25/24/25 | 6.78 | -0.88% | 5,726 |
Delayed Quote Warsaw S.E., May 02, 2024 at 09:25 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
-11.83% | 17.21M | |
-2.97% | 250B | |
+12.81% | 19.77B | |
0.00% | 17.89B | |
+0.38% | 11.09B | |
-6.84% | 10.36B | |
+16.90% | 7.75B | |
+10.15% | 5.97B | |
-1.01% | 4.52B | |
-17.67% | 3.8B |
- Stock Market
- Equities
- PHR Stock